Skip to main content

Table 3 Serum levels of TNF-α, IL-12 and IL-13 in brucellosis patients and control groups with different genotypes

From: Evaluation of the relationship between IL-12, IL-13 and TNF-α gene polymorphisms with the susceptibility to brucellosis: a case control study

SNPs

Groups/Genotypes

Serum levels

 

p- value b

IL-13 (−1512A/C)

 

Serum IL-13 levels (pg/ml)

 

0.07

Genotypes

AA

AC

CC

p-value a

Case (n = 107)

2.29 ± 2.31

4.87 ± 16.06

2.47 ± 0.60

< 0.001

Control (n = 107)

1.89 ± 1.28

2.41 ± 1.68

1.62 ± 1.14

< 0.001

p-value C

0.58

0.16

0.21

  

IL-13(−1112 C/T)

Genotypes

CC

CT

TT

 

0.187

Case (n = 107)

2.47 ± 1.62

4.59 ± 16.06

3.29 ± 3.08

< 0.001

Control (n = 107)

1.82 ± 1.27

2.34 ± 1.66

2.21 ± 1.46

< 0.001

p-value C

0.24

0.19

0.26

  

TNF-α (−238 G/A)

 

Serum TNF-α levels (pg/ml)

 

0.718

Genotypes

AA

AG

GG

 

Case (n = 107)

15.71 ± 63.22

10.22 ± 16.50

< 0.001

Control (n = 107)

1.28 ± 1.39

1.72 ± 1.54

< 0.001

p-value C

0.02

0.07

  

IL-12 (+1188 A/C)

 

Serum IL-12 levels (pg/ml)

 

0.172

Genotypes

AA

AC

CC

 

Case (n = 107)

2.71 ± 1.69

4.85 ± 5.47

3.28 ± 1.20

< 0.001

Control (n = 107)

2.60 ± 1.67

2.70 ± 2.10

2.66 ± 2.03

< 0.001

p-value C

0.89

0.003

0.02

  
  1. a p-value was calculated based on one-sample Chi-square test, the genotypes frequencies were compared in case and control separately
  2. b p-value was calculated based on Chi-square test in a contingency table
  3. c p-value was calculated based on independent t-test/Mann-Whitney test